Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 328
7
Diseases
19
Unique genes
0.213
Avg. similarity score
Blindness
Most-connected disease (4 links)
Disease
Searched: Microphthalmia/coloboma 3
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Microphthalmia/coloboma 3
Blindness
Microphthalmia with cataracts and iris abnormalities
Microphthalmia, isolated 2
Retinal disorder
Epileptic encephalopathy, early infantile, 38
Hereditary spastic paraplegia 11
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Blindness | 4 | 4 | 14 |
| Microphthalmia with cataracts and iris abnormalities | 4 | 4 | 1 |
| Microphthalmia, isolated 2 | 4 | 4 | 1 |
| Microphthalmia/coloboma 3 | 4 | 4 | 1 |
| Retinal disorder | 4 | 4 | 6 |
| Epileptic encephalopathy, early infantile, 38 | 1 | 1 | 1 |
| Hereditary spastic paraplegia 11 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| VSX2 | 5 / 7 | Blindness, Microphthalmia with cataracts and iris abnormalities, Microphthalmia, isolated 2, Microphthalmia/coloboma 3 and 1 more |
| ARV1 | 2 / 7 | Blindness, Epileptic encephalopathy, early infantile, 38 |
| SPG11 | 2 / 7 | Hereditary spastic paraplegia 11, Retinal disorder |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| The canonical retinoid cycle in rods (twilight vision) | Reactome | 3 / 20 | 94.8× | 3.76e-6 | 1.30e-4 ✓ sig. |
| Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56) | Reactome | 1 / 1 | 632× | 1.58e-3 | 1.60e-2 ✓ sig. |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | Reactome | 1 / 9 | 70.2× | 1.42e-2 | 7.00e-2 |
| Activation of the phototransduction cascade | Reactome | 1 / 9 | 70.2× | 1.42e-2 | 7.00e-2 |
| Opsins | Reactome | 1 / 10 | 63.2× | 1.57e-2 | 7.46e-2 |
| Purine ribonucleoside monophosphate biosynthesis | Reactome | 1 / 12 | 52.7× | 1.88e-2 | 8.28e-2 |
| Miscellaneous substrates | Reactome | 1 / 12 | 52.7× | 1.88e-2 | 8.28e-2 |
| Passive transport by Aquaporins | Reactome | 1 / 12 | 52.7× | 1.88e-2 | 8.28e-2 |
| Retinoid cycle disease events | Reactome | 1 / 13 | 48.6× | 2.04e-2 | 8.67e-2 |
| Processing of SMDT1 | Reactome | 1 / 16 | 39.5× | 2.50e-2 | 9.76e-2 |
| G0 and Early G1 | Reactome | 1 / 18 | 35.1× | 2.81e-2 | 1.04e-1 |
| VxPx cargo-targeting to cilium | Reactome | 1 / 21 | 30.1× | 3.27e-2 | 1.14e-1 |
| Cholesterol biosynthesis | Reactome | 1 / 21 | 30.1× | 3.27e-2 | 1.14e-1 |
| Phototransduction | KEGG | 1 / 29 | 21.8× | 4.49e-2 | 1.36e-1 |
| Antifolate resistance | KEGG | 1 / 30 | 21.1× | 4.64e-2 | 1.39e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| visual perception | GO:0007601 | 8 / 215 | 36.6× | 1.83e-11 | 6.57e-9 ✓ sig. |
| photoreceptor cell maintenance | GO:0045494 | 4 / 45 | 87.4× | 1.11e-7 | 1.38e-5 ✓ sig. |
| phototransduction, visible light | GO:0007603 | 3 / 13 | 227× | 2.53e-7 | 2.76e-5 ✓ sig. |
| camera-type eye development | GO:0043010 | 4 / 74 | 53.2× | 8.39e-7 | 7.43e-5 ✓ sig. |
| sensory perception of light stimulus | GO:0050953 | 2 / 13 | 151× | 7.59e-5 | 2.52e-3 ✓ sig. |
| retina homeostasis | GO:0001895 | 2 / 15 | 131× | 1.02e-4 | 3.14e-3 ✓ sig. |
| retinal metabolic process | GO:0042574 | 2 / 19 | 104× | 1.66e-4 | 4.44e-3 ✓ sig. |
| response to light stimulus | GO:0009416 | 2 / 28 | 70.3× | 3.64e-4 | 7.70e-3 ✓ sig. |
| phototransduction | GO:0007602 | 2 / 34 | 57.9× | 5.39e-4 | 9.93e-3 ✓ sig. |
| retinoid metabolic process | GO:0001523 | 2 / 38 | 51.8× | 6.74e-4 | 1.16e-2 ✓ sig. |
| peptidyl-tyrosine phosphorylation | GO:0018108 | 2 / 39 | 50.4× | 7.10e-4 | 1.19e-2 ✓ sig. |
| phagosome-lysosome fusion involved in apoptotic cell clearance | GO:0090389 | 1 / 1 | 984× | 1.02e-3 | 1.48e-2 ✓ sig. |
| zeaxanthin biosynthetic process | GO:1901827 | 1 / 1 | 984× | 1.02e-3 | 1.48e-2 ✓ sig. |
| regulation of plasma membrane sterol distribution | GO:0097036 | 1 / 1 | 984× | 1.02e-3 | 1.48e-2 ✓ sig. |
| ciliary basal body-plasma membrane docking | GO:0097711 | 1 / 2 | 492× | 2.03e-3 | 2.14e-2 ✓ sig. |